Treatment · June 16, 2026
US FDA Accepts Gilead’s New Weekly Pill for HIV Prevention
FDA acceptance of Gilead's new drug application represents progress toward bringing a new therapeutic option to patients....
Breakthrough · June 10, 2026
Twice-Yearly HIV Shot Shows Why Federal Research Funding Matters
Lenacapavir represents a major HIV breakthrough, demonstrating the critical impact of NIH research funding....